Recon: Moderna ends development of CMV vaccine; ICER finds launch prices for drugs ‘significantly’ higher than inflation
ReconJason Scott
Biologics/ biosimilars/ vaccinesEuropeGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicyUnited States